Clonidine Hcl 100Mcg Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.1 MG, 0.025 MG
Reference Brands: Kapvay (USA), Dixarit (EU/UK)
Category:
Heart Disorder
Clonidine is a medicine used in the treatment of hypertension (high blood pressure). It lowers the blood pressure by relaxing the blood vessels. Lowering the blood pressure helps to prevent future stroke and heart attack.
Clonidine HCL 100mcg Tablet is available in Tablets
and strengths such as 0.1 MG, 0.025 MG.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clonidine HCL 100mcg Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clonidine HCL 100mcg Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clonidine is a centrally acting alpha-2 adrenergic and imidazoline receptor agonist widely used in clinical practice for its ability to reduce blood pressure and heart rate by decreasing sympathetic nervous system activity. By lowering peripheral vascular resistance and promoting vasodilation, clonidine helps improve myocardial perfusion and reduces cardiac workload, making it an effective therapy for hypertension and related cardiovascular conditions.
Beyond its antihypertensive role, clonidine has multiple FDA-approved and clinically established indications. It is used in the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients, management of tics associated with Tourette syndrome, and as an adjunct therapy in severe cancer-related pain. Its central mechanism of action allows clonidine to modulate both cardiovascular and neurological pathways, contributing to its broad therapeutic utility.
Clonidine is available in various formulations and strengths, allowing flexible dosing and individualized treatment based on patient needs. Proper understanding of its pharmacology, dosing considerations, potential adverse effects, and drug interactions is essential to ensure safe and effective use. When prescribed and monitored appropriately, clonidine remains a valuable option across diverse patient populations,
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing